Skip to content

GeneDx Holdings WGS Price / book

Price / book at other companies

Natera, Inc. logo
Natera, Inc.NTRA
16×+0.6×
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
19.4×-6.1×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
1.1×+0.1×
Quest Diagnostics logo
Quest DiagnosticsDGX
2.9×+0.2×
Revvity logo
RevvityRVTY
1.4×-0.3×
Labcorp Holdings logo
Labcorp HoldingsLH
2.5×+0.2×

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$1.72B-24.3%
Enterprise value$1.73B-22.8%
P/S3.9×-3.0×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%
Net margin-17.6%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Calculated from GeneDx Holdings’s reported figures.

Based on the most recent quarter.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GeneDx Holdings's price / book?
GeneDx Holdings (WGS) reported price / book of 7.4× in Q1 2026.
How has GeneDx Holdings's price / book changed year-over-year?
GeneDx Holdings's price / book decreased by 23.4% year-over-year, from 9.7× to 7.4×.
What is the long-term trend for GeneDx Holdings's price / book?
Over 4 years (2021 to 2025), GeneDx Holdings's price / book has grown at a -39.6% compound annual growth rate (CAGR), from 91.6× to 12.2×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.